Company

Newport Pharmaceuticals Limited is involved in the development, manufacture and marketing of medicinal products for the treatment of infectious disease, immunological disorders and related conditions.

Through commercial in-licensing of relevant technology, its ongoing research and clinical development programmes, out-licensing of its intellectual property and sales of its medicinal products the Newport strategy is focused on revenue growth and enhancement through innovation. The company is market and revenue orientated through a global distribution network yet recognises the need for technological innovation and advancement.